memantine NDC 62135-896

NDC codes

FDA NDC Directory

Product NDC (as listed)62135-896Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62135-0896Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
62135-896-60	62135089660	60 TABLET in 1 BOTTLE (62135-896-60)Marketed from Feb 1, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): memantine
Generic name (nonproprietary): memantine
Active ingredients: Memantine hydrochloride — 10 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Chartwell RX, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 090244
Marketing start: Jul 11, 2018
Listing expires: Dec 31, 2026
Other FDA classes: NMDA Receptor Antagonists (Mechanism)
Identifiers: Product ID 62135-896_f3ba0986-42cf-a016-e053-2995a90a7c9fSPL ID f3ba0986-42cf-a016-e053-2995a90a7c9fSPL set ID 6906b0b4-1944-40f0-844a-e0db72ba4675RxCUI 996561, 996571UNII JY0WD0UA60UPC 0362135895600, 0362135896607
Pharmacologic class: N-methyl-D-aspartate Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462135089660 followed by a unit qualifier and the quantity

Package 62135-0896-60. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 2, 2023.

Indications (excerpt from the label)

Memantine hydrochloride tablets, USP are indicated for the treatment of moderate to severe dementia of the Alzheimer’s type. Memantine hydrochloride tablets, USP are an N-methyl-D-aspartate (NMDA) receptor antagonist indicated for the treatment of moderate to severe dementia of the Alzheimer’s type. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 090244

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 090244
Product	Strength	Form · route	Labeler	Product NDC
memantine	Memantine hydrochloride 5 mg/1	TabletOral	Chartwell RX, LLC	62135-895